XML 26 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
REVENUE:        
Revenue $ 134,521 $ 134,397 $ 388,265 $ 394,611
OPERATING EXPENSES:        
General and administrative expense, exclusive of depreciation expense shown below 10,688 8,642 34,799 30,690
Depreciation 3,529 3,551 10,683 10,909
Amortization 65 125 298 380
Other (income) expense, net (5,590) (4,529) (6,222) (6,073)
OPERATING INCOME 20,928 19,803 40,636 44,382
Interest expense 2,650 3,108 7,963 9,740
Income before income taxes 18,278 16,695 32,673 34,642
Income tax expense 3,754 4,691 7,411 9,958
Net income 14,524 12,004 25,262 24,684
Net income attributable to non-controlling interest 285 259 541 687
Net income attributable to Core Laboratories Inc. $ 14,239 $ 11,745 $ 24,721 $ 23,997
EARNINGS PER SHARE INFORMATION:        
Basic earnings per share $ 0.31 $ 0.26 $ 0.54 $ 0.53
Basic earnings per share attributable to Core Laboratories Inc. 0.31 0.25 0.53 0.51
Diluted earnings per share 0.31 0.25 0.53 0.52
Diluted earnings per share attributable to Core Laboratories Inc. $ 0.3 $ 0.25 $ 0.52 $ 0.5
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:        
Basic 46,263 46,922 46,552 46,897
Diluted 47,078 47,820 47,381 47,690
Service [Member]        
REVENUE:        
Revenue $ 101,125 $ 98,842 $ 292,435 $ 291,674
OPERATING EXPENSES:        
Cost of services and product sales exclusive of depreciation expense shown below 74,896 75,503 221,929 224,191
Product [Member]        
REVENUE:        
Revenue 33,396 35,555 95,830 102,937
OPERATING EXPENSES:        
Cost of services and product sales exclusive of depreciation expense shown below $ 30,005 $ 31,302 $ 86,142 $ 90,132